On Patient Experience and Anxiety During Treatment With Magnetic Resonance–Guided Radiation Therapy

IF 2.2 Q3 ONCOLOGY Advances in Radiation Oncology Pub Date : 2024-05-04 DOI:10.1016/j.adro.2024.101537

Jasmijn M. Westerhoff MD , Pim T.S. Borman PhD , Reijer H.A. Rutgers BSc , Bas W. Raaymakers PhD , Neil Winchester MSc , Helena M. Verkooijen PhD , Martin F. Fast PhD

{"title":"On Patient Experience and Anxiety During Treatment With Magnetic Resonance–Guided Radiation Therapy","authors":"Jasmijn M. Westerhoff MD , Pim T.S. Borman PhD , Reijer H.A. Rutgers BSc , Bas W. Raaymakers PhD , Neil Winchester MSc , Helena M. Verkooijen PhD , Martin F. Fast PhD","doi":"10.1016/j.adro.2024.101537","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>To assess patient experience and anxiety during magnetic resonance (MR)–guided radiation therapy (MRgRT) using a hybrid 1.5Tesla (T) MR-guided linear accelerator (MR-Linac) when offered calming video content.</p></div><div><h3>Methods and Materials</h3><p>A single-center study was conducted within the Multi-Outcome Evaluation of Radiation Therapy Using the MR-Linac (MOMENTUM) cohort. Patients were offered to watch calming video content on a video monitor during treatment. Questionnaires were used to assess patient experience (MR-Linac patient-reported experience) and anxiety (State-Trait Anxiety Inventory, STAI) at first treatment fraction (M1) and at third, fourth, or fifth treatment fraction (M2). Paired <em>t</em> tests were used to test for significant differences, and effect sizes (ESs) were used to estimate the magnitude of the difference.</p></div><div><h3>Results</h3><p>Between November 2021 and November 2022, 66 patients were included. The majority were men (n = 59, 89%). MRgRT was most frequently delivered to prostate cancer (n = 45, 68%) followed by a lesion in the pancreas (n = 8, 12%). At M1 and M2, 24 of 59 patients (41%) preferred to watch calming video content. One patient was not able to look at the video monitor comfortably at M1. Patient experience was generally favorable or neutral; tingling sensations were reported by 17% of patients. Anxiety levels were high (16%), moderate (18%), or low to none (67%) prior to M1. STAI scores were 33 (SD, 9) prior to M1 and 29 (SD, 7) after M1 (ES, 0.7; <em>P</em> < .001). STAI scores were 32 (SD, 9) prior to M2 and 31 (SD, 8) after M2 (ES, 0.4; <em>P</em> = .009).</p></div><div><h3>Conclusions</h3><p>Patients were able to comfortably view the video monitor during MRgRT. Consequently, this setup could be used for future applications, such as biofeedback. A sizable minority of patients preferred to watch calming videos that distracted them during treatment. Although the patients’ experience was overall excellent, anxiety was reported. Anxiety levels were highest prior to treatment and decreased after treatment.</p></div>","PeriodicalId":7390,"journal":{"name":"Advances in Radiation Oncology","volume":"9 8","pages":"Article 101537"},"PeriodicalIF":2.2000,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452109424001003/pdfft?md5=607d9c8c23bc2ef27ab2d5ee8d674bb2&pid=1-s2.0-S2452109424001003-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452109424001003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose

To assess patient experience and anxiety during magnetic resonance (MR)–guided radiation therapy (MRgRT) using a hybrid 1.5Tesla (T) MR-guided linear accelerator (MR-Linac) when offered calming video content.

Methods and Materials

A single-center study was conducted within the Multi-Outcome Evaluation of Radiation Therapy Using the MR-Linac (MOMENTUM) cohort. Patients were offered to watch calming video content on a video monitor during treatment. Questionnaires were used to assess patient experience (MR-Linac patient-reported experience) and anxiety (State-Trait Anxiety Inventory, STAI) at first treatment fraction (M1) and at third, fourth, or fifth treatment fraction (M2). Paired t tests were used to test for significant differences, and effect sizes (ESs) were used to estimate the magnitude of the difference.

Results

Between November 2021 and November 2022, 66 patients were included. The majority were men (n = 59, 89%). MRgRT was most frequently delivered to prostate cancer (n = 45, 68%) followed by a lesion in the pancreas (n = 8, 12%). At M1 and M2, 24 of 59 patients (41%) preferred to watch calming video content. One patient was not able to look at the video monitor comfortably at M1. Patient experience was generally favorable or neutral; tingling sensations were reported by 17% of patients. Anxiety levels were high (16%), moderate (18%), or low to none (67%) prior to M1. STAI scores were 33 (SD, 9) prior to M1 and 29 (SD, 7) after M1 (ES, 0.7; P < .001). STAI scores were 32 (SD, 9) prior to M2 and 31 (SD, 8) after M2 (ES, 0.4; P = .009).

Conclusions

Patients were able to comfortably view the video monitor during MRgRT. Consequently, this setup could be used for future applications, such as biofeedback. A sizable minority of patients preferred to watch calming videos that distracted them during treatment. Although the patients’ experience was overall excellent, anxiety was reported. Anxiety levels were highest prior to treatment and decreased after treatment.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

磁共振引导放射治疗过程中的患者体验和焦虑

目的评估患者在使用混合型 1.5 特斯拉 (T) 磁共振引导直线加速器（MR-Linac）进行磁共振引导放射治疗（MRgRT）过程中，在提供镇静视频内容时的体验和焦虑。方法和材料在使用 MR-Linac 的放射治疗多成果评估（MOMENTUM）队列中开展了一项单中心研究。患者可在治疗过程中通过视频监视器观看镇静视频内容。在第一次治疗分期（M1）和第三次、第四次或第五次治疗分期（M2）时，使用问卷评估患者的体验（MR-Linac 患者报告体验）和焦虑（状态-特质焦虑量表，STAI）。结果2021年11月至2022年11月期间，共纳入66名患者。大多数患者为男性（n = 59，89%）。MRgRT 最常用于前列腺癌（45 人，68%），其次是胰腺病变（8 人，12%）。在 M1 和 M2 阶段，59 位患者中有 24 位（41%）喜欢观看镇静视频内容。一名患者在 M1 时无法舒适地观看视频监视器。患者的体验普遍良好或中性；17% 的患者报告有刺痛感。M1 前的焦虑水平为高度（16%）、中度（18%）或低度至无（67%）。M1 前，STAI 得分为 33（标准差，9），M1 后为 29（标准差，7）（ES，0.7；P < .001）。M2 前的 STAI 得分为 32（标清，9），M2 后为 31（标清，8）（ES，0.4；P = .009）。因此，这种设置可用于生物反馈等未来应用。相当一部分患者喜欢在治疗过程中观看能分散注意力的镇静视频。虽然患者的总体体验很好，但也有焦虑的报告。焦虑水平在治疗前最高，治疗后有所下降。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Advances in Radiation Oncology Medicine-Radiology, Nuclear Medicine and Imaging

CiteScore

4.60

自引率

4.30%

发文量

208

审稿时长

98 days

期刊介绍： The purpose of Advances is to provide information for clinicians who use radiation therapy by publishing: Clinical trial reports and reanalyses. Basic science original reports. Manuscripts examining health services research, comparative and cost effectiveness research, and systematic reviews. Case reports documenting unusual problems and solutions. High quality multi and single institutional series, as well as other novel retrospective hypothesis generating series. Timely critical reviews on important topics in radiation oncology, such as side effects. Articles reporting the natural history of disease and patterns of failure, particularly as they relate to treatment volume delineation. Articles on safety and quality in radiation therapy. Essays on clinical experience. Articles on practice transformation in radiation oncology, in particular: Aspects of health policy that may impact the future practice of radiation oncology. How information technology, such as data analytics and systems innovations, will change radiation oncology practice. Articles on imaging as they relate to radiation therapy treatment.